Natco Pharma Q4 Results: Profit Misses Estimates, Margin Contracts; FY26 Outlook Gloomy

Natco Pharma Ltd. reported slower-than-expected earnings growth in the final quarter of FY25 as it prepares for a turbulent new year due to Trump’s tariff policies. Consolidated net profit rose…